Effect of simvastatin on IL-6 and adiponectin secretion and mRNA expression in 3T3-L1 adipocytes

  • Yin Xiaoming  (殷晓明)
  • Tu Ling  (涂玲)
  • Yang Huiqing  (杨慧清)
Article

Summary

In order to investigate the effects of simvastatin on secretion and mRNA expression of interleukin-6 (IL-6) and adiponectin in 3T3-L1 adipocytes, mouse 3T3-L1 adipocytes were stimulated with lipopolysaccharide (LPS). Production and mRNA expression of IL-6 and adiponectin in 3T3-L1 adipocytes were measured using enzyme-linked immunosorbent assay (ELISA) and reverse transcriptase polymerase chain reaction (RT-PCR), respectively. The results showed that simvastatin could significantly suppress LPS-induced IL-6 production and mRNA expression in adipocytes (P<0.05), but increase the LPS-induced adiponectin secretion and mRNA expression in a dose-dependent manner (P<0.05). It was suggested that simvastatin could exert beneficial effects on prevention of obesity-induced metabolic changes in adipocytes.

Key words

obesity adipocyte adiponectin simvastatin interleukin-6 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wellen K E, Hotamisligil G S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest, 2003,112:1785–1788PubMedCrossRefGoogle Scholar
  2. 2.
    Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci, 1999,892:146–154PubMedCrossRefGoogle Scholar
  3. 3.
    Maeda K, Okubo K, Shimomura I et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun, 1996,221:286–289PubMedCrossRefGoogle Scholar
  4. 4.
    Woods A, Brull D J, Humphries S E et al. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J, 2000,21:1574–1583PubMedCrossRefGoogle Scholar
  5. 5.
    Bernlohr D A, Angus C W, Lane M D et al. Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein. Proc Natl Acad Sci U S A, 1984,81:5468–5472PubMedCrossRefGoogle Scholar
  6. 6.
    Das U N. Pathophysiology of metabolic syndrome X and its links to the perinatal period. Nutrition, 2005,21:762–773PubMedCrossRefGoogle Scholar
  7. 7.
    Yudkin J S, Stehouwer C D, Emeis J J et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol, 1999,19:972–978PubMedGoogle Scholar
  8. 8.
    Bullo M, Garcia-Lorda P, Megias I et al. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res, 2003,11:525–531PubMedCrossRefGoogle Scholar
  9. 9.
    Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem, 2003,278:45 777–45 784CrossRefGoogle Scholar
  10. 10.
    Fasshauer M, Klein J, Lossner U et al. Interlenkin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone and IL-6 in 3T3-L1 adipocytes. Horm Metab Res, 2003,35:147–152PubMedCrossRefGoogle Scholar
  11. 11.
    Fried S K, Bunkin D A, Greenberg A S et al. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab, 1998,83:847–850PubMedCrossRefGoogle Scholar
  12. 12.
    Chen C, Li Z, Li J. Anti-inflammatory effect of cerivastatin in vascular injury independent of serum cholesterol and blood pressure lowering effects in mouse model. Chin J Traumatol (Chinese), 2002,5:294–298Google Scholar

Copyright information

© Huazhong University of Science and Technology 2007

Authors and Affiliations

  • Yin Xiaoming  (殷晓明)
    • 1
  • Tu Ling  (涂玲)
    • 2
  • Yang Huiqing  (杨慧清)
    • 1
  1. 1.Department of Geriatric MedicineAnqing Municipal HospitalAnqingChina
  2. 2.Department of Integration, Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina

Personalised recommendations